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A number of cell surface structures are thought to belong to the Ig superfamily
(IgSF) t because they contain at least one domain with a characteristic folding pat-
tern, called the Ig fold (reviewed in reference 1) . Several of these molecules have
critical functions in immune responses . In addition to ensuring specific antigen rec-
ognition (Ig, TCR), they may function as monomorphic ligands critical in cell-cell
interactions (e.g ., ICAM, CD4, CD8), receptors for viruses (e.g ., CD4, ICAM),
or lymphokine receptors (e.g ., IL-1-R, IL-6-R) .
We report here the characterization of a novel human gene, termed lymphocyte
activation gene 3 (LAG-3), selectively transcribed in activated NK and T lympho-
cytes . It codes for a membrane protein with four extracellular IgSF domains . The
sequence data, the compared exon/intron organization, and the chromosomal local-
ization revealed that LAG-3 is closely related to CD4.
Materials and Methods
Cell Lines.
￿
The isolation and growth of the fetal CD3 - CD2` F55111E5 (or F5) cloned
cell line has been described elsewhere (2) . For mass production, the cell suspensions were
plated on a feeder layer composed of irradiated allogeneic PBL plus the EBVtransformed
B cell line Laz388 in Vbottomed 96-well plates at 3,000 cells per well with rIL-2 and
lymphocyte-conditioned medium . 200 plates were harvested at a concentration of 3 x 106
cells/ml after 12 d in culture to give 6 x 109 cells . For the Northern blot analyses, similar
culture conditions were used to produce the relevant cells .
Isolation ofMembrane-bound (MB) Cytoplasmic RNA and Construction ofacDNA Sublibrary.
￿
4 x
109 F5 cells were washed twice in PBS and allowed to swell for 5 min at a concentration of
5 x 108 cells/ml in ice-cold hypotonic buffer medium RSB (0.01M KCI, 0.0015 M MgC12,
0.01 M Tris-HCI, pH 7.4) (3) . The cells were then ruptured mechanically with 10 strokes
ofa tight-fitting glass homogenizer (Dounce). The homogenate was diluted fivefold in 2 .5
M sucrose TKM buffer (0.15M KCL, 0.005 M MgC12, 0.05M Tris-HCI, pH 7.4) and
layered over 2 vol of 2 .5 M sucrose TKM buffer. Two layers .of sucrose TKM buffer were
successively added, one with 2.05M sucroseanda second with 1.3M sucrose . The gradients
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were centrifuged for 5 h at 4°C in an SW 27.1 rotor (Spinco) at 25,000 rpm. The tubes were
punctured at the interface between the 2 .05 and 1 .3 M sucrose layers. After two extractions
by phenol-chloroform and precipitation by ethanol, the poly(A)' mRNA was prepared by
oligo(dT) column chromatography (4). sscDNA was synthesized using reverse transcriptase
primed with oligo(dT). dscDNA was synthesized from poly(A)' RNA derived from the
MB-F5 material according to the method of Gubler and Hoffman (5). After protection of
internal Eco RI sites by Eco RI methylase and size selection on an ultra low temperature
agarose gel (>500 bp), the dscDNAs were cloned into the Eco RI site of X gt10 using linkers
(6). The resulting X gt10-cDNA hybrids were then packaged in vitro using a commercial pack-
aging extract (Amersham Corp., Arlington Heights, IL). After plating on Escherichia coli C600
Hfl', we obtained 6 x 10' recombinant phages.
Isolation and Characterization of LAG-3 cDNA Clones.
￿
The MB-F., cDNA library (2 x 10'
recombinant phages) was plated on E. coli C600/Hfl (103 phages per plate) . Screening of
filters was carried out according to standard procedures, except that Gene Screen Plus (Dupont
Co., Wilmington, DE) nylon membranes were used. Hybridizations were done for 16 h at
42°C in 50% formamide, 5 x SSC, 5% Denhart's solution, 100,ug/ml denatured salmon sperm
DNA, and 5 x 106 dpm/ml 32p-labeled ssDNA MB-F5 subtracted probe. Filters were washed
in 1 x SSC, 0.5% SDS at 65°C twice, followed by washing in 0.1 x SSC, 0.1% SDS at 42°C .
The cDNA inserts were subcloned into PBS, a T3T7 transcriptional promoter containing
vector (Stratagene, LaJolla, CA). To isolate cDNA clones that contain additional 5' sequences,
we screened in turn three different TCR-,y/6' cell-derived X gt10 libraries containing cDNA
primed either with oligo(dT), with random hexamers, or with a specific primer (nucleotides
704-688 of sequence FDC in Fig. 1). 32P-labeled ssRNA FD47 probe was transcribed in vitro
from the linearized pBS plasmid using T7 polymerase in the presence of 10 AM 32P-UTP
(800 Ci/mmol') (7) and used to screen the first cDNA library to obtain clone FD19 (see
Fig. 1). Subsequently, a 0.3-kb Barn HI-Hind III genomic fragment that corresponds to the
more 5' region of the fourth exon (Fig. 2) was labeled by the hexamer-priming method (8)
and used to screen the second library to obtain clones FD61 and FD101, and the third library
to obtain a near full-length 5' sequence containing cDNA (FD191).
The sequences of clones FD47 and FD19 were determined directly from ds supercoiled
plasmids in both directions with an universal M13 primer or a reverse M13 primer using
the dideoxy chain termination procedure (9) and the modified T7 polymerase (United States
Biochemical Corp., Cleveland, OH). The sequences of FD61, FD101, and FD191 were deter-
mined from ssDNA after cloning in either the M13mp18 or the M13mp19 vectors. Compar-
ison of amino acid sequences to known Ig-related domains was done using the ALIGN pro-
gram with a bias of 6, a break penalty of 6, and 150 random runs (1).
Northern and Southern Blot Analysis.
￿
RNA was prepared from the cytoplasmic fraction of
cells lysed in hypotonic buffer in the presence ofNP-40. Total RNA was purified by two phenol-
chloroform extractions, followed by two ethanol precipitations. The RNA preparations (10
mg/slot) were dissolved in water, heated at 50°C for 1 h in the presence of 1 M glyoxal, 50%
DMSF, and run in a 1% agarose gel at 50 V for 3 h. The gels were then soaked in 10 x SSC
for 30 min, and the RNA was transferred on two Gene Screen Plus nylon membranes.
For the Southern blot analysis, high molecular weight genomic DNA samples (10 mg) were
digested with either Eco RI, Hind III, Barn HI, or XbaI, subjected to electrophoresis through
0.7% agarose, and blotted in alkaline buffer onto Gene Screen Plus nylon membranes.
32P-labeled DNA probes were prepared from agarose-purified fragments by the hexamer
random priming method (8). The nylon filters were prehybridized in 50% formamide, 5 x
SSC, 5 x Denhardt's solution, 100 Fcg/ml salmon sperm DNA, 10°Jo polyethylene glycol 6000
for 4 h at 42'C, and then hybridized in the same buffer with 106 dpm/ml 32P-labeled cDNA
probe at 42 °C for 16 h. Filters were washed twice for 30 min in 1 x SSC, 0.5% SDS at 65'C,
followed by a 30-min wash in 0.1 x SSC, 0.1% SDS at 42°C.
Molecular Cloning of the LAG-3 Gene.
￿
Genomic DNA clones were isolated from the LY67
library made with partial Mbo I-digested DNA from a human EBVtransformed B cell line
inserted into X2001 (10). The FD47 insert was labeled using the hexamer random priming
method and used to screen 2 x 105 plaques of this human genomic DNA library. Nine posi-
tive plaques were isolated (GD1 to GD9), and phage DNA were characterized by restrictionTRIEBEL ET AL.
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mapping using the FD19 probe, which contains half of the protein coding region and the
3' untranslated region. Two overlapping 16.4-kb Eco RI and 11.5-kb Hind III DNA frag-
ments were generated and subcloned into the plasmid pUN121 (11) to give the GD3 Eco and
GDl Hind clones. Detailed restriction maps of these subclones were constructed and com-
pared with the restriction map ofthe FDC sequence shown in Fig. 1. Various restriction frag-
ments were obtained from ultra-low temperature agarose gels and subcloned into bacterio-
phageM13mp18 or M13mp19. The sequences ofthese fragments were determined from ssDNA
usingthe dideoxy chain termination procedure (9) and the modified T7 polymerase (United
States Biochemical Corp.). 17-base oligonucleotides, whose sequences were derived from ei-
ther the cDNA FD19 (positions 497-513 in Fig. 1 B) or from the sequence of the 5' flanking
region of the LAG-3 gene (positions -421 to -437 in Fig. 3), were synthesized and used
in the sequencing project.
Chromosomal Localization by In Situ Hybridization.
￿
In situ hybridization was performed ac-
cording to a previously described method (12). The GD3Eco fragment (16.4 kb) was labeled
with Bio-11-dUTP (Bethesda Research Laboratories, Gaithersburg, MD). The hybridized
probewas visualized on chromosomes afterindirect immunofluorescence; an antibiotin anti-
body was used to detect the biotinylated probe and a IgG fluorescein conjugate was used
as a second antibody. Chromosomes were counterstained by propidium iodide and pho-
tographed.
Results and Discussion
Isolation of a LAG-3-specific cDNA Clonefrom the MB-F55IIIE5 Sublibrary.
￿
Experi-
ments were designed to isolate cDNA clones expressed selectively in an IL-2-dependent
CD3- NK cell line termed F5. The MB-F5 expression library was prepared using
mRNA extracted from MB polyribosomes on sucrose gradients. Such libraries are
enriched in RNA (<10To of the total mRNA) encoding either membrane-anchored
or secreted proteins. MB-F5 was screened with a cDNA probe obtained by subtrac-
tion of the MB F5 mRNA with mRNA from a series of transformed cells, including
Jurkat (T cell leukemia), Laz 388 (EBVtransformed B lymphoblastoid cell line),
K562 (erythro-myeloid leukemia), and U937 (histiocytic origin). 0.5% (120 clones)
of the X GT10 recombinant phages present in the MB-F5 library were selected with
this screening procedure. One 400-bp clone, termed FD47, was studied because it
hybridized to a 2-kb transcript expressed in the F5 cells while being absent from
Jurkat, Laz 388, K562, and U937 (data not shown).
Isolation and Structure ofa Near Full-length LAG-3 cDNA.
￿
To obtain longer cDNA,
we prepared three additional libraries from a TCR.y/S+ cloned cell line. These cells
were used because their mRNA was found to hybridize strongly with FD47 . A first
library was obtained from mRNA primed with oligo(dT) leading to the character-
ization of the 1,004-bp FD19 clone (Fig. 1 a). Because FD19 accounted for only half
the size of the transcript, a second library was prepared using random hexamer oli-
gonucleotide priming. The clones FD61 and FD101 obtained by this approach were
further informative with respect to the upstream sequence of the LAG-3 mRNA.
Finally, it is with a third library primed with a specific oligonucleotide corresponding
to the 5' region of the FD19 cDNA (nucleotides 704-688 of the sequence shown in
Fig. 1 b) that a 5' sequence including the initiation codon ATG was obtained in clone
FD191.
Using these overlapping clones that spanned a total length of 1,871 bp, we estab-
lished the nucleotidic sequence, termed FDC (Fig. 1 b), of the LAG-3 transcript.
The LAG-3 mRNA has a long open reading frame encoding a 498-amino acid pro-1396
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1 TCArCCTGCC 7-1-C, AGCrrrCCAO
61 CCTCCCCACC C CTCTCCAA GGCCCICTCC
121 CACCTCCCTC TCTGCAGAAC TTCTCCTTTA
181 TTT'TCTGACC TCCTITTGGA GGGCTCAGCG
241 CTCAGTTCCT OGGCTTGCTG TTRCTGCAGC
301 A000AGGGGC TGAGGTCCCG GTGGTGTGGG
361 GCAGCCCCAC AATCCCCCTC CAGGATCTCA
421 AGCATCAGCC AGACAGTGGC CCGCCCGCTG
481 CTCACCCGGC CGCGCCCTCC TCCTGGGGGC
541 TGGGTCCCGG AGCCCTGCGC AGCGGGIGGC
601 AGCGCGOCCG GCAGCGCGGG GACTTCTCGC
661 CCGGCGAGTA CCCCGCCGCG GTGCACCTCA
721 TGCGCCIGGG CCAGGCCTCG ATGACIGCCA
781 GGGTCATTTT GAACTGCTCC TTCAGCCGCC
841 GGAACCGGGG CCAGGGCCGA GTCCCTGTCC
901 GCTTCCTCTT CCTGCCCCAA GTCAGCCCCA
961 CCTACAGAGA TGGCTTCIIAC GTCTCCATCA
1021 CCCCAACTCC CTT2ACAGTG TACGCTGGAG
1081 T3CCTGCTGG TGTGGGGICC CCGTCSTTCC
1141 GCCCTGACCT CCTGGTGACT OGAGACAATG
1201 GCCAOGCCCA GGCTGGGACC TACACCTGCC
1261 CCACTGTCAC ATTGGCIUITC ATCACAGTGA
1321 TG000AAGCT GCTTTGTGIG GTGACTCCAG
1381 CTCTGGACAC CCCATCCCAG AGGAGTTTCT
1441 AOCTCCTTTC CCAGCCTTOG CAATGCCAGC
1501 CAGTGTACTT CAGIGAGCTC TCTAGCCCAG
1561 CCCICCCAGC AGGCCACCTC CTGCTGTTTC
1621 TOGTGACTGO AGCCTTTGGC TTTCACCTTT
1681 CTGCCTTAGA GCAAGGGATT CACCCTCOCA
1741 AGAACCGGAG CCGGAGCCGG AGCCGGAACC
1801 GCTCTGACCT GGAGCTGAGG CAGCCAGCAG
1861 TGTCTAGCAG C
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CTTTCCTCTG GATTCCGGCC TCTGGTCATC
TGGTCTCCCT TCTRCTAGAA CCCCTTCCTC
CCCCCCACCC CCCACCACTG CCCCCTTT'CC
CTGCCCAGAC CATAGGAGAG ATaTOGGAGG
CGCTTTGGGT GGCICCAGTG AAGCCTCTCC
CCCAGGAGGG GGCTCCTGCC CAGCTCCCCT
GCCTTCTGCG AAGAGCAGGG GTCACrTGGC
CCGCCCCCGG CCATCCCCTG GCCCCCGGCC
CCAGGCCCCG CCGCTACACG GTGCTGAGCG
TGCCCCTGCA GCCCCGCGTC CAGCTOOATG
TATGGCTGCG CCCAGCCCGG CGCGCGGACG
GGGACCGCGC CCTCTCCTGC CGCCTCCGTC
GCCCCCCAGG ATCTCT:AGA GCCTCCGACT
CTGACCGCCC AGCCTCTGTG CATTGGTTCC
GGGAGTCCCC CCATCACCAC TTAGCGGAAA
TGGACTCTGG GCCCTGGGGC TGCATCCTCA
TGTATIUICCT CACTGTTCTG GGTCTGGAGC
CAGGTTCCAG GGTGGGGCTG CCCTGCCGCC
TCACTGCCAA GTGGACTCCT CCTGGGGGAG
GCGACTiTAC CCTTCGACTA GAGGITGTGA
ATATCCATCT GCAGGUICAG CAGCTCAATG
CTCCCAAATC CTTTGGGTCA CCTGGATCCC
TATCTGGACA AOAACGCTTT GTGTCGAGCT
CAGGACCTTG GCTOGAGGCA CAGGAGGCCC
TGTACCAGGG GGAGAGGCTT CTTGGAGCAG
OTGCCCAACG CTCTGGGAGA GCCCCAGGTG
TCACCCTTGG TCTCCTTTCT CTGCTCCTTT
GGAGAAGACA GTGGCGACCA AGACGATTTT
GGCTCAGAGC AAGAZ&QACG AGCTGGAGCA
GGAGCCCOAG CCCGAGCCCG AOCCGGIGCA
ATCTCAGCAG CCCAGTCCAA ATA"CGTCC
FIGURE 1.
￿
(a)Restriction map
ofFDC, a sequence derived by
contiguity from overlapping hu-
man LAG-3 cDNA clones. FD47
and FD19 were isolated from in-
dependently derived oligo-dTpri-
med cDNA libraries. FD61 and
FD101 were obtained from a
hexamer random-primed cDNA
library. FD191 is derived from
an LAG-3-specific oligomer-
primed (positions 704- 688 of
sequence FDC) cDNA library.
The protein-coding region is
boxed. The shaded region rep-
resents the mature polypeptide
after cleavage ofthe leader pep-
tide. (6) Nucleotide sequence of
lymphocyte cDNA clones en-
coding the human LAG-3 an-
tigen. The methionine initiation
codon and the stop codon are
underlined. This sequence,
termed FDC, was derived by
contiguity from five overlapp-
ing LAG-3 cDNA (clones FD47,
FD19, FD61, FD101, andFD191).
These sequence data have been
submitted to the EMBL/Gen-
Bank Data Libraries under the
accession numbers X51984 and
X51985.
tein. The sequence surrounding thepresumed startcodon (GAGATGT) is compat-
ible with the Kozak consensus sequence (13). In the 3'-untranslated region, there
is a single consensuspolyadenylation site at position 1619. Using an alignment pro-
gram based on a dynamic programming algorithm (14), the analysis of the LAG-3
cDNA revealed no significant local homologies with sequences available in theGen-
Bank database.
Isolation and Structure of the LAG-3 Gene.
￿
Nine genomic clones (25-35 kb) were
isolated from a human genomic DNA library with the FD19 probe. These clones
were characterized by Southern blot hybridization and were found to display the
same restriction map using the various LAG-3 probes. Overlapping fragments of
twoselected subclones, designated GDl Hind and GD3 Eco (Fig. 2 a), were charac-
terized by further restriction mapping and partial nucleotide sequencing. The map
of the LAG-3 locus, from the 5' Sph I to the 3' Bgl II sites, is shown in Fig. 2 a.
The LAG-3 gene spans -6.6 kb and includes eightexons. A series ofsequences (data
not shown) was performed to study the precise exon-intron organization. All the
introns displayed the appropriate GT and AG splicing donor/acceptor sites at their
extremities (data not shown).b
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CCTGCAATGTCATTCTTTGAGCTCAGTTCCTCATCTCTGTCATGGAGAGCATTAGATTTCATGAATTCATACTAAGTGTCCAATACAGTGC'iTAGCA -901
CGTAATGAAGCGTCAATACAATGTAGTTATTCTCCATGCCCCACAAAGCTGCATGCCTAGCCTCAGACCTACCATTTMTGGGGTGCAGTAAGGCTTCCT -801
GTCCACCATGTTCCCAGGGACATTGTACTGATGGGTGGAAAGGCAGGTCTAAAGGGGTCACGAAGTTCTGGGAGGTTAAGGGAACGAGGAAGGAGATTGA -701
GCAACAAGGAAAGAGCTTGCCAAGAAGGAGGTGTGAATATTrdAGACTGAGGAGGCAGCTTAGAGATGGGCMGGGGGCAGTTCCAGGCAGAAATGGTTCG -601
TGGAGGCAGAAGGTCCCTGGGAGAGGGAGCAGTCTGGAGGGTGGGGCAGGGGCGAGGAGGGGGAGGTGGGGAGACCCAGGACTGAGGAAGTAAACAAGGG -501
GAGCGCCACCACAGAGGTGGAGAGGTGGAGGGTGCIGCTGCTGGGAATCAACCCCCTCAGACTTTCCACTGCGUIGCGAAACCGTAAGCCCTGGGGTGCG -401
GgGGQ=2"'GGGAGGAGGGGAAGTGGGGIAGGTGGAGGGAAGGCCGGGCACAGGGGTGAAGGCCCAGAGACCAGCAGAACGGCATCCCAGCCACGACG -101
GCCACTTTGCTCTGTCTGCTGTCCGCCACGGCCCTGCTCTGTTCCCTGGGACACCCCCGCCCCCACCTCCTCAGGCTGCGTGATCTGCCCAGCTTTCCAG -201
CTTTCCTCTGGATTCCGGCCTCTGGTCATCCCTCCCCACCCTCTCTCCAAGGCCCTCTCCTGGTCTCCCTTCTTCTAGAACCCCTTCCTCCACCTCCCTC -101
TCTGCAGAACTTCTCCTTTACCCCCCACCCCCCACCACTGCCCCCTTTCCTTTTCTGACCTCCTrr GGAGGGCTCAGCGCTGCCCAGACCATAGGAGAG -1
+1
FIGURE 2 .
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(a) Structure ofthehuman LAG-3 gene in chromosomal DNA . The signal peptide
(L), V -like (V), C-like (C), transmembrane (TM), andcytoplasmic (CYT) regions are boxed .
The map was constructed by single and double endonuclease digestions of X 2001 clones GD1
and GD3 and their subclones GD3 Eco and GDl Hind, as well as from nucleotide sequencing .
(b) Nucleotide sequence ofthe promoter region of the human LAG-3 gene. The arrow indicates
the first nucleotide of theFDC cDNA sequence. TheATG (+1), the inverted CCAAT box, and
the GC box (Spl-binding site) are underlined .
In the promoter region (Fig . 2 b), no TATA box is found upstream of the 239-bp
5' untranslated sequence . An Sp 1 binding site that contains the typical GGGCGG
core hexanucleotide (15) is located at position -389 from the translation initiation
site . AnATTGGsequence (CCAATboxin reverse), known to be an important com-
ponent of several promoters (16), is present at position -662 .
To further characterize the LAG-3 gene, DNAs from the K562 myeloid tumor
cell line and from polyclonal IL-2-dependent T and NK cell lines were digested by
either Eco RI, Hind III, BamHI, orXba I restrictionenzymes . Southern blot hybridi-
zations were performed using theFDC probe (1,871 bp) that had been constructed
by fusing the 5' Eco RI/Hind III fragment of clone FD191 to the 3' Hind III/Eco
RI fragment of clone FD19 . Three Eco RI fragments (2, 8.2, and 10 kb), two Hind
III fragments (5.7 and 9.5 kb), three Bam HI fragments (2.8, 4, and 13 kb), and
threeXba I fragments (3, 4, and6 kb)were detected (datanot shown) . These results,
in accordance with the restriction map of the genomic clones, indicated that the
LAG-3 gene is present in the human haploid genome as a single copy gene .
Expression of the LAG-3 Gene.
￿
The 1,004-bp clone FD19 was used as a probe to
analyze the expression of the LAG-3 gene in a series of hematopoietic and non-
hematopoietic cells (Fig . 3) . There was no message in the transformed cell lines of
T, B, and myeloid origin (Jurkat, Laz 388, K562, U937 ; Fig. 3 a, lanes 1-4) that1398
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FIGURE 3 .
￿
Expression ofthe LAG-3 gene. (a) Cellular distribution as deduced from RNA blot
hybridization . Total cytoplasmic RNA were prepared from the following cells: lane 1, Jurkat ;
lane 2, Laz 388 ; lane 3, K562 ; lane 4, U937 ; lanes 5, 6, and 7, three CD3- NK cell lines
(F55111E5, SIIH4, SIIIG5); lanes 8, 9, 10, and 11, four CD3* TCRa/S' cloned cell lines F55C8
and F55B4 (CD4'), and SIF8 and F5511IG5 (CD8') ; lane 12, the CD3' TCR7/b' BK clone;
lane 13, macrophages derived from PBL; lane 14, purified T cells ; lane 15, SKN-AS, a neuro-
blastoma cell line ; lane 16, brain tissue ; lane 17, PLC-PRF5, a hepatoma cell line. (b) Kinetics
ofLAG-3 expression in T cell blasts . Lane 0, uninduced lymphocytes; lanes 1-5, PBL activated
with PHA for 1, 2, 3, 4, and 5 d, respectively.
have been used for the subtraction procedures . Additional T cell tumors including
CEM andMOLT -4 were also found to be negative (data not shown), as well as pe-
ripheral blood monocytes (Fig . 3 a, lane 14), two cultured neuroblastoma cell lines
(one shown in lane 15), fresh brain tissue (lane 16), and a tumor cell line of hepatic
origin (lane 17) .
Resting lymphocytes (Fig. 3 b, lane 1) as well as resting purifiedT cells (Fig. 3
a, lane 13) were negative . A series of normal T andNK IL-2-dependent clones and
polyclonal cell lines described previously (2, 17, 18) were assessed. ThetranscriptionTRIEBEL ET AL.
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of the LAG-3 gene was detected as a single species mRNA of ti2 kb in all these
activated lymphocytes. Fig. 3 a displays data representative ofthevarious subpopu-
lations tested: lanes 5-7, three CD3- NK cell lines; lanes 8-11, four CD3+ TCR
a/a+ lines, including two CD4+ and two CD8+ cells; lane 12, 1 CD3+ TCR-y/b+
cell line.
These data supported the view that the LAG-3 protein corresponds to a broadly
expressed(i.e., not restricted to aunique subset) lymphocyte activation antigen. The
kineticparameters ofthis expression were tested afterPHA stimulationofPBL. Fig.
3 b shows that the expression ofthe LAG-3 gene is undetectable in restingPBL and
peaks at days 3-4 after PHA stimulation.
Structure ofthe LAG-3 Protein.
￿
The characteristics ofthe LAG-3 protein, shown
in Fig. 4, have been deduced from the structure ofthe gene and from the analysis
of its translation product. It appears as a type I membrane protein encoded by 498
amino acids (aa). The mature protein includes 470 as with a predicted molecular
mass of 51,295 daltons and a pl of 10.9. The hydrophobic leader peptide (28 aa)
is encoded by both exon I (19 aa) and exon II (9 as out of 50). The extra-cellular
region is encoded by exons II (41 as out of50), III (101 aa), IV (90 aa), V(92 aa),
andVI (81 aa); the transmembrane region (TM) by exon VII (44 aa); andthe highly
charged cytoplasmic region by exon VIII (21 aa). The extracellular region includes
eight cysteine residuesand fourpotential N-linked glycosylation sites (Asn-X-Ser, Thr).
The peptidic stretch encoded by exons II and III corresponds to a V-SET IgSF
domain (1), including /3 strands A, B, C, C, C", D, E, F, and G, with two unusual
features. First, this V domain includes an extra loop of -30 amino acids encoded
by the first part ofexon III. This loop shown in Fig. 4 bjoins (3 strand C to /3 strand
C' and contains 10 proline residues. It seems that such an insertion might be com-
patible with IgSF fold since it does not disrupt thecore ofthe fold that is considered
to consist of/3 strands A, B, E and G, F, C (19). Differences in V and C domains
occur in the middle ofthe fold, and also an alternatively spliced exon that can be
inserted in the coding sequence for N-CAM domain 4 occurs in this region (20).
The second unusual point is that the downstream cysteine ofdomain 1 seemslikely
to be in the (3 strand G position rather than in a strand F (residue 121), as is almost
invariably the case(Fig. 4 b). The patternofAsp x Gly x Tyr x Cys is very charac-
teristic in the 0 strand F position, and this is present, except that an Ala is in the
Cys position. It seem possible than a disulphide bond as shown in Fig. 4 b might
form and it should be noted that an unusual disulphide bond of a different kind
has been reported in the Vlike domain of CD8a chain (21).
An Arg-Gly-Asp (RGD) sequence is found in (3 strand E (Fig. 4 b). This motif
is known to represent a potential adhesiotope (22), but it is dubious that its forms
the core of a major binding site since, at this position (+101), such a sequence is
probably exposed within the IgSF fold.
Exons IV, V, andVIencode IgSF-relateddomains(1)with 51, 50, and 42 aa, respec-
tively, between the two conserved cysteine residues. These three domains have C-
type folds and show sequence patterns characteristic ofthe C2-SET (1). They were
scored against C2-SET sequences with theALIGN program (23, 24): of57 sequences
tested, scores of >3 SD were obtained 32, 41, and 11 times for domain 2, 3, and
4, respectively. Domain 4 belongs to the truncated C2-SET since it lacks strand D.
LAG-3 domains 1 and 2 were aligned by eye with domains 3 and 4, taking into1400
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a
FIGURE 4.
￿
(a) Schematic diagram of LAG-3.
The domains are designed as L (leader), V (V
set IgSF domain), C2 (C2 set IgSF domain), TM
(transmembrane), and CYT (cytoplasmic). The
cysteine residues that form disulfide linkages are
indicated. The position of introns is marked by
arrows. The carbohydrate sites (16) and the RGD
(') sequence (putative cell attachment sites) are
indicated. (b) A model for LAG-3 domain 1. The
sequence of the first Ig domain (aa +1 to +139)
is displayed according to .the format used by
Amzel and Poljak (36). The disulphide bond is
indicated and the RGD sequence is boxed.
account identities and structural considerations (Fig. 5 a). Since domain 1 contains
an extra loop of sequence, the alignment was started at as 91 in this domain and
at as 276 in domain 3. Out of 129 possible matches between residues, there are 34
identities, 35 similarities, and 9 breaks (alignment score + 8.5 SD). Moreover, in
a strand F of domains 2 and 4 there is a sequence W x C that is most unusual
at this position, where the sequence Y or F x C is commonly found (1). Taken to-
gether, the data suggests that LAG-3 has evolved by gene duplication from a pre-
existing two-domain structure resembling that of an Ig L chain.
One of the most prominent characteristics of LAG-3 is its structural relationship
with CD4. Indeed, an alignment of sequences with some notable patchesof identity
can be made as shown in Fig. 5 b. Two large gaps are inserted to allow forthe extra
loop of sequence in LAG-3 domain 1 and for the fact that CD4 domain 3 is of V
SET type, while LAG-3 domain 3 is of C2-SET type. The patches of similarity in-
clude the start of domain 1 (nine identities and six similarities out of 17 possible
matches), and thevery unusual W x C sequence in LAG-3 domains 2 and 4, which
are also present at the corresponding positions in CD4. This sequence motifis not
seen in an equivalent position in anyotherIgSF domains. Overall, there are 87 iden-
tities and 82 similarities out of 338 residues aligned (19 breaks) when the extracel-
lularregions ofLAG-3 and rat CD4are compared. As in the LAG-3 structure, notable
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FIGURE 5.
￿
(a) Sequence alignments showinginternal homology in theLAG-3molecule. Amino
acid sequencesin domain 1 (startingat position 119 aftertheextra loop) anddomain 2 arelined
up with thecorresponding positionsin domains 3 and4. Identities areindicated by (')andsimilar-
ities by (-). (b) Alignments of LAG-3 and rat CD4 (37) amino acid sequences, and position of
introns. The dotted lines abovethe sequences indicate the positions of putative fl strands in the
four IgSF domains. The strands arelabeled as in reference 1. Theputative leader (L)and trans-
membrane (TM) sequences are marked by a straight line above the sequence. The position of
introns is marked by arrows above the sequence (for LAG-3) and below the sequence (for CD4
accordingto reference 38 for human CD4). Identities are indicatedby an asterisk and similari-
ties by a period.1402
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patches of internal sequence homologies are found in the CD4 molecule between
domains 1 and 2, as well as between domains 2 and4(25) . More generally, theexon-
intron organization ofLAG-3 andCD4 is very similar : both genes includean intron
within the first IgSF domain, and the position of the introns (marked by arrows in
Fig . 5 b) in LAG-3 is very close to that of CD4.
It has been previously suggested that CD4 has evolved by gene duplication from
a.pre-existingtwo-IgSF structure (25) . Thepresent findings strengthen this hypoth-
esis and support the view that CD4 and LAG-3 may have shared a common four-
domain evolutionary ancestor.
ChromosomalLocation oftheLAG-3 Gene.
￿
In light ofthe likely relationship between
LAG-3 andCD4 genes, it was of interest to compare their location on the genome.
The human CD4 gene has been shown to be located on chromosome 12 (26, 27),
with a regional assignment corresponding to band pter-p12 (27) . In situ hybridiza-
tion was performed on human chromosomes using a 16 .4-kb biotinylated LAG-3
genomic probe andindirect immunofluorescence . Greenfluorescent spots were recur-
rently observed on the distal segment of the short arm of a middle-sized chromo-
some (Fig . 6, a and b) . R-banding ofthe metaphases showing these fluorescent spots
indicated that the LAG-3 probe is localized on chromosome 12 on the p13 .3 band
(Fig . 6 c) . More precisely, the LAG-3 gene position on chromosome 12 is likely to
be assigned to thep13.32band because green spots were not distally located on pl3 .3
in the majority of the cells examined . The frequency of metaphases with at least
one spot on one of the four chromatidesofchromosomes 12was 75 ,76 . Veryfewother
spots (two or three per cell, according to the probe concentration) were observed
in the karyotype on the other chromosomes .
Thus, the positions ofboth LAG-3 andCD4 genes in the human genome arevery
similar since the regional assignment of CD4 (pter-pl2) includes band p13.3 . This
observation confirmed that both genes are likely to derive from acommon evolu-
tionary ancestor.
FIGURE 6 .
￿
Chromosomal localization of theLAG-3 gene by in situ hybridization ofbiotinylated
LAG-3 probe on human chromosomes. Arrows indicate chromosome 12 . (a and b) Fluorescein
detection of hybridized sites and propidium iodide counterstaining . (c) R banding of chromo-
somes shown in b .In light ofthe present data, one cannot exclude that the LAG-3 protein may have
biological propertiessimilar to that of CD4 with respect to interactions with MHC
gene products (28, 29) or with viral proteins (30, 31).
More generally, LAG-3 may function like many other IgSF molecules as a ligand
for membrane-anchored or soluble proteins. Among IgSF members whose expres-
sion is upregulated upon cell activation, examples include ICAM-1, known to be
involved in cell-cell interactions (32), and IL-1-R . or IL-6-R, which function as receptors
for growth factors (33, 34). Note that ICAM-1 has also been shown recently to rep-
resent a major receptor for rhinoviruses (35). Further studies will be needed to test
these working hypotheses on the LAG-3 function.
Summary
We have identified a novel human gene of the Ig superfamily, designated LAG-3.
Expression ofthis gene is undetectable in resting PBL, while it is found (a 2-kb mes-
sage) in activated T and NK cells. The LAG-3 gene includes eight exons; the corre-
sponding cDNA encodes a 498-amino acid membrane protein with four extracel-
lular IgSF domains. The first one belongs to the V-SET; it is particular since it includes
an extra loop in the middle of the domain and an unusual intrachain disulphide
bridge. The threeother domains belong to the C2-SET Strong internal homologies
are found in the LAGA molecule between domains 1 and 3, as well as between do-
mains 2 and 4. It is therefore likely that LAGA has evolved by duplication of a pre-
existing gene encoding a two IgSF-domain structure. The compared analysis of LAG-3
and CD4, with respect to both their peptidic sequence as well as their exon/intron
organization, indicated that the two molecules are closely related. This point is
strengthened by the finding that both genes are located on the distal part ofthe short
arm of chromosome 12.
We thankAlan F. Williams for his precious help in the detailed comparison between LAG-3
and other IgSF molecules, particularly CD4.
Receivedfor publication 21 December 1989.
TRIEBEL ET AL.
￿
1403
References
1 . Williams, A. F. 1987. A year in the life of the immunoglobulin superfamily. Immunol.
Today. 8:298.
2 . Nowill, A., P Moingeon, A. Ythier, M. Graziani, F. Faure, L. Delmon, M. Rainaut,
F. Daffos, C. Bohuon, and T Hercend. 1986. Natural killer clones derived from fetal
(25 wk) blood: probing the human T cell receptor with WT31 monoclonal antibody.
J . Exp. Med. 163:1601.
3 . Mechler, B., and T. H. Rabbitts. 1981. Membrane-bound ribosomes of myeloma cells
IV. mRNA complexity of free and membrane-bound polysomes. J. Cell Biol. 88:29.
4 . Aviv, H., and P Leder. 1972. Purification ofbiologically active globin messenger RNA
by chromatography on oligothymidilic acid cellulose. Proc. Natl. Acad Sci. USA. 69:1408.
5 . Gubler, U., and B. J. Hoffman. 1983. A simple and very efficient method for generating
cDNA libraries. Gene. 25:263.
6 . Huynh, T. V., R. A. Young, and.R. W. Davis. DNA Cloning: A practical approach.
D. Glover, editor. IRL Press. Oxford. 49-78.
7. Triebel, F., M. Graziani, F. Faure, S. Jitsukawa, and T. Hercend. 1987. Cloned human1404
￿
A HUMAN GENE CLOSE TO CD4
CD3- lymphocytes with NK-like activity do not express nor rearrange TCR gamma
genes. Eur. J Immunol. 17:1209.
8. Feinberg, A. P., and B. Vogelstein. 1983 . A technique for radiolabeling DNA restriction
endonuclease fragments to high specific activity. Anal. Biochem. 132 :6.
9. Sanger, F, S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating
inhibitors. Proc. Nail. Acad. Sci. USA. 74:5463.
10. Dariavach, P., G. Lefranc, and M. P Lefranc. 1987 . Human Immunoglobulin Clambda6
gene encodes the Kern + Oz=lambda chain and Clambda4 and Clambda5 are pseu-
dogenes. Proc. Nall. Acad. Sci. USA. 84:9074.
11 . Triebel, F., R. Breathnach, M . Graziani, T. Hercend, and P. Debre. 1988. Evidence for
expression of two distinct T cell-receptor beta chain transcripts in a human diphtheria
toxoid specific T cell clone. J Immunol. 140:300.
12. Viegas-Pequignot, E., B. Dutrillaux, H. Magdelenat, and M . Coppey-Mosian. 1989.
Mapping of single-copy DNA sequences on human chromosomes by in situ hybridiza-
tion with biotinylated probes: enhancement ofdetection sensitivity by intensified-fluores-
cence digital imaging microscopy. Proc. Nall. Acad. Sci. USA. 86:582.
13. Kozak, M. 1984. Compilation and analysis of sequences upstream from the translational
start site in eukaryotic mRNAs. Nucleic Acids Res. 12 :857.
14. Goad, W. B., and M. 1. Kanehisa. 1982. Pattern recognition in nucleic acid sequences.
I. A. general method for finding localhomologies and symmetries. NucleicAcidsRes. 10:247.
15. Kadonaga, J. T, K. A. Jones, and R. Tijan. 1986. Promoter-specific activation ofRNA
polymerase 11 transcription by Spl. TIBS (Trends Biochem. Sci.) 11:20.
16. Mcknight, T. D., D. C . Alexander, M. S. Babcock, and R. B. Simpson. 1986. Nucleotide
sequence and molecular evolution of two tomato genes encoding the small subunit of
ribulose-1, 5-bisphosphate carboxylase. Gene (Amst.). 48:23.
17. Triebel, F, F. Faure, M. Graziani, S. Jitsukawa, M. P Lefranc, and T. Hercend. 1988.
A unique VJ-C rearranged gene encodes a -y protein expressed on the majority of CD3'
TCRa//3-circulating lymphocytes. J Exp. Med. 167:694.
18 . Faure, F, S. Jitsukawa, F. Triebel, and T. Hercend. 1988. CD3/Ti gamma A: a func-
tional gamma receptor complex expressed on human peripheral lymphocytes.J Immunol.
140:1372.
19. Lesk, A. M., and C. Chothia. 1982. Evolution of proteins formed by beta-sheets. II.
The core of the Ig domains. J Mol. Biol. 160:325 .
20 . Santoni, M. J., D. Barthels, G. Vopper, A. Boned, C. Goridis, and W. Wille. 1989. Differen-
tial exon usage involving an unusual splicing mechanism generates at least eight types
of NCAM cDNA in mouse brain. EMBO (Eur. Mol. Biol. Organ.)) 8:395 .
21 . Kirszbaum, L., J. A. Sharpe, N. Goss, J. Lahnstein, and I. D. Walker. 1989. The alpha-
chain of murine CD8 lacks an invariant Ig-like disulfide bond but contains a unique
intrachain loop instead. J . Immunol. 142 :3931.
22 . Ruoslahti, E., and M. D. Pierschbacher. 1986. Arg-Gly-Asp, a versatile cell recognition
signal. Cell. 44:517.
23 . Dayhoff, M. O., W. C . Barker, and L. T. Hunt. 1983. Establishing homologies in protein
sequences. Meth. Enzymol. 91:524.
24 . Williams, A. F., and A. N. Barclay. 1988. The immunoglobulin superfamily domains
for cell surface recognition. Annu. Rev. Immunol. 6:381.
25 . Williams, A. F, S. J. Davis, (.Z, He, and A. N. Barclay. 1989. Structural diversity in do-
mains of the immunoglobulin superfamily. ColdSpring Harbor Symp. Quant. Biol. In press.
26. Kozbor, D., J . Finan; P. C . Nowell, and C. M. Croce. 1986. The gene encoding the T4
antigen maps to human chromosome 12. J Immunol. 136:1141.
27. Isobe, M., K. Huebner, P. J. Maddon, D. R. Littman, R. Axel, and C. M. Croce. 1986.TRIEBEL ET AL.
￿
1405
The gene encoding the T-cell surface protein T4 is located on human chromosome 12.
Proc. Natl. Acad Sci. USA. 83:4399.
28. Doyle, C., andJ. L. Strominger. 1987. Interaction between CD4 and class II MHC mol-
ecules mediates cell adhesion. Nature (Loud.). 330:256.
29. Mazerolles, F, A. Durandy, D. Piatier-Tonneau, D. Charron, L. Montagnier, C. Auffray,
and A. Fischer. 1988. Immunosuppressive properties of synthetic peptides derived from
CD4 and HLA-DR antigens. Cell. 55:497.
30. Clayton, L. K., R. E. Hussey, R. Steinbrich, H . Ramachandran, Y. Husain, and E.
Reinherz. 1988. Substitution of murine for human CD4 residues identifies amino acids
critical for HIVgp120 binding. Nature (Land.). 335:363.
31 . Peterson, A., and B. Seed. 1988. Genetic analysis ofmonoclonalantibody and HIV binding
sites on the human lymphocyte antigen CD4. Cell. 54:65.
32. Simmons, D., M. W. Makgoba, and B. Seed. 1988. ICAM, an adhesion ligand of LFA-1,
is homologous to the neural cell adhesion molecule NCAM. Nature (Lond). 331 :624.
33 . Sims, J. E., C.J. March, D. Cosman, M. B. Widmer, H. R. MacDonald, C. J . McMahan,
C. E. Grubin, J. M. Wignall, J. L. Jackson, S. M. Call, D. Friend, and S. K. Dower.
1988. cDNA expression cloning of the IL-1 receptor, a member ofthe immunoglobulin
superfamily. Science (Wash. DC. 241:585.
34. Yamasaki, K., T. Taga, Y. Hirata, H. Yawata, Y. Kawanishi, B. Seed, T. Taniguchi, T.
Hirano, and T. Kishimoto. 1988. Cloning and expression of the human interleukin-6
(BSF2/IFNbeta 2) receptor. Science (Wash. DC. 241 :825.
35. Greve, J. M., G. Davis, A. M. Meyer, C. P Forte, S. C. Yost, C. W. Marlor, M. E.
Kamarck, and A. McClelland. 1989. The major humanrhinovirus receptor is ICAM-1 .
Cell. 56:839.
36 . Amzel, L. M., and R. J. Poljak. 1979. Three dimensional structure of Igs. Annu. Rev.
Biochem. 48:961 .
37 . Clark, S. J., W. A. Jefferies, N. Barclay, J. Gagnon, and A. F. Williams. 1987. Peptide
and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a
structure with four immunoglobulin-related domains. Proc. Natl. Acad. Sci. USA. 84:1649.
38 . Maddon, P. J., S. M. Molineaux, D. E. Maddon, K. A. Zimmerman, M. Godfrey, F. W.
Alt, L. Chess, and R. Axel. 1987. Structure and expression of the human and mouse
T4 genes. Proc. Nad. Acad. Sci. USA. 84:9155.